NovaBay Pharmaceuticals, Inc. financial data

Symbol
NBY on NYSE
Location
Emeryville, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 210% % 90%
Quick Ratio 15% % -75%
Debt-to-equity 103% % -78%
Return On Assets 55% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126,010,749 shares 2479%
Common Stock, Shares, Outstanding 6,011,000 shares 23%
Entity Public Float $2,979,107 USD -2.3%
Common Stock, Value, Issued $60,000 USD 22%
Weighted Average Number of Shares Outstanding, Basic 5,876,000 shares 409%
Weighted Average Number of Shares Outstanding, Diluted 5,876,000 shares 409%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $42,000 USD 24%
Selling and Marketing Expense $4,034,000 USD -14%
General and Administrative Expense $7,571,000 USD 13%
Operating Income (Loss) $6,665,000 USD -0.7%
Income Tax Expense (Benefit) $400,000 USD
Net Income (Loss) Attributable to Parent $3,243,000 USD -6.7%
Earnings Per Share, Basic 31 USD/shares 89%
Earnings Per Share, Diluted -0.22 USD/shares 89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,309,000 USD 198%
Accounts Receivable, after Allowance for Credit Loss, Current $704,000 USD
Inventory, Net $467,000 USD -33%
Other Assets, Current $49,000 USD -58%
Assets, Current $2,898,000 USD 27%
Property, Plant and Equipment, Net $6,000 USD -90%
Operating Lease, Right-of-Use Asset $189,000 USD -82%
Other Assets, Noncurrent $394,000 USD -20%
Assets $3,487,000 USD -10%
Accounts Payable, Current $76,000 USD -81%
Employee-related Liabilities, Current $450,000 USD 56%
Accrued Liabilities, Current $807,000 USD -30%
Liabilities, Current $1,448,000 USD -27%
Operating Lease, Liability, Noncurrent $405,000 USD -51%
Liabilities $1,853,000 USD -34%
Retained Earnings (Accumulated Deficit) $183,817,000 USD -0.86%
Stockholders' Equity Attributable to Parent $1,109,000 USD 3.5%
Liabilities and Equity $3,487,000 USD -10%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,324,000 USD 33%
Net Cash Provided by (Used in) Financing Activities $1,708,000 USD -186%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 6,011,000 shares 23%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,037,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,702,000 USD 116%
Interest Paid, Excluding Capitalized Interest, Operating Activities $8,000 USD -97%
Deferred Tax Assets, Valuation Allowance $42,238,000 USD 2.9%
Deferred Tax Assets, Gross $42,483,000 USD 2.7%
Operating Lease, Liability $821,000 USD -32%
Depreciation $23,000 USD -30%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $854,000 USD -34%
Property, Plant and Equipment, Gross $404,000 USD -46%
Operating Lease, Liability, Current $416,000 USD 6.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $290,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year One $444,000 USD 1.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33,000 USD -58%
Lessee, Operating Lease, Liability, to be Paid, Year Three $290,000 USD -35%
Deferred Tax Assets, Operating Loss Carryforwards $40,689,000 USD 10%
Preferred Stock, Shares Issued 1 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $974,000 USD 0%
Operating Lease, Payments $403,000 USD -4.7%
Additional Paid in Capital $181,074,000 USD -1.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $148,000 USD -49%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%